Logo image of NVST

ENVISTA HOLDINGS CORP (NVST) Stock Fundamental Analysis

USA - NYSE:NVST - US29415F1049 - Common Stock

19.45 USD
+0.23 (+1.2%)
Last: 10/14/2025, 8:04:00 PM
19.45 USD
0 (0%)
After Hours: 10/14/2025, 8:04:00 PM
Fundamental Rating

4

Overall NVST gets a fundamental rating of 4 out of 10. We evaluated NVST against 191 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of NVST get a neutral evaluation. Nothing too spectacular is happening here. NVST has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year NVST was profitable.
In the past year NVST had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: NVST reported negative net income in multiple years.
Each year in the past 5 years NVST had a positive operating cash flow.
NVST Yearly Net Income VS EBIT VS OCF VS FCFNVST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B

1.2 Ratios

NVST has a Return On Assets of 0.95%. This is in the better half of the industry: NVST outperforms 73.30% of its industry peers.
The Return On Equity of NVST (1.71%) is better than 73.82% of its industry peers.
Looking at the Return On Invested Capital, with a value of 2.95%, NVST is in the better half of the industry, outperforming 71.73% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for NVST is below the industry average of 8.89%.
Industry RankSector Rank
ROA 0.95%
ROE 1.71%
ROIC 2.95%
ROA(3y)-6.24%
ROA(5y)-2.61%
ROE(3y)-11.58%
ROE(5y)-5.09%
ROIC(3y)4.17%
ROIC(5y)4.15%
NVST Yearly ROA, ROE, ROICNVST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

With a decent Profit Margin value of 2.11%, NVST is doing good in the industry, outperforming 74.35% of the companies in the same industry.
With a decent Operating Margin value of 7.13%, NVST is doing good in the industry, outperforming 74.87% of the companies in the same industry.
NVST's Operating Margin has declined in the last couple of years.
NVST has a Gross Margin (54.79%) which is in line with its industry peers.
NVST's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.13%
PM (TTM) 2.11%
GM 54.79%
OM growth 3Y-26.92%
OM growth 5Y-10.43%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.9%
GM growth 5Y-1.29%
NVST Yearly Profit, Operating, Gross MarginsNVST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NVST is destroying value.
Compared to 1 year ago, NVST has more shares outstanding
NVST has more shares outstanding than it did 5 years ago.
The debt/assets ratio for NVST is higher compared to a year ago.
NVST Yearly Shares OutstandingNVST Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
NVST Yearly Total Debt VS Total AssetsNVST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 1.46, we must say that NVST is in the distress zone and has some risk of bankruptcy.
NVST has a Altman-Z score (1.46) which is comparable to the rest of the industry.
NVST has a debt to FCF ratio of 5.60. This is a neutral value as NVST would need 5.60 years to pay back of all of its debts.
The Debt to FCF ratio of NVST (5.60) is better than 79.06% of its industry peers.
NVST has a Debt/Equity ratio of 0.46. This is a healthy value indicating a solid balance between debt and equity.
NVST has a Debt to Equity ratio of 0.46. This is comparable to the rest of the industry: NVST outperforms 45.03% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 5.6
Altman-Z 1.46
ROIC/WACC0.43
WACC6.92%
NVST Yearly LT Debt VS Equity VS FCFNVST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

NVST has a Current Ratio of 2.44. This indicates that NVST is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 2.44, NVST perfoms like the industry average, outperforming 48.69% of the companies in the same industry.
A Quick Ratio of 2.08 indicates that NVST has no problem at all paying its short term obligations.
NVST has a Quick ratio (2.08) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.44
Quick Ratio 2.08
NVST Yearly Current Assets VS Current LiabilitesNVST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

The earnings per share for NVST have decreased strongly by -21.10% in the last year.
Measured over the past years, NVST shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -28.29% on average per year.
The Revenue has been growing slightly by 0.76% in the past year.
Measured over the past years, NVST shows a small growth in Revenue. The Revenue has been growing by 1.90% on average per year.
EPS 1Y (TTM)-21.1%
EPS 3Y-28.29%
EPS 5YN/A
EPS Q2Q%136.36%
Revenue 1Y (TTM)0.76%
Revenue growth 3Y0.02%
Revenue growth 5Y1.9%
Sales Q2Q%7.74%

3.2 Future

NVST is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 33.46% yearly.
NVST is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.74% yearly.
EPS Next Y55.01%
EPS Next 2Y30.76%
EPS Next 3Y24.3%
EPS Next 5Y33.46%
Revenue Next Year4.74%
Revenue Next 2Y4.03%
Revenue Next 3Y3.67%
Revenue Next 5Y7.74%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NVST Yearly Revenue VS EstimatesNVST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
NVST Yearly EPS VS EstimatesNVST Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 22.62, which indicates a rather expensive current valuation of NVST.
78.53% of the companies in the same industry are more expensive than NVST, based on the Price/Earnings ratio.
NVST is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.50, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 15.58 indicates a correct valuation of NVST.
NVST's Price/Forward Earnings ratio is rather cheap when compared to the industry. NVST is cheaper than 84.29% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.99, NVST is valued a bit cheaper.
Industry RankSector Rank
PE 22.62
Fwd PE 15.58
NVST Price Earnings VS Forward Price EarningsNVST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NVST is valued cheaply inside the industry as 84.29% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, NVST is valued cheaply inside the industry as 95.81% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 12.53
EV/EBITDA 12.03
NVST Per share dataNVST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
NVST's earnings are expected to grow with 24.30% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.41
PEG (5Y)N/A
EPS Next 2Y30.76%
EPS Next 3Y24.3%

0

5. Dividend

5.1 Amount

No dividends for NVST!.
Industry RankSector Rank
Dividend Yield N/A

ENVISTA HOLDINGS CORP

NYSE:NVST (10/14/2025, 8:04:00 PM)

After market: 19.45 0 (0%)

19.45

+0.23 (+1.2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)10-29 2025-10-29/amc
Inst Owners119.06%
Inst Owner Change0.01%
Ins Owners0.46%
Ins Owner Change1.64%
Market Cap3.23B
Analysts73
Price Target21.98 (13.01%)
Short Float %6.22%
Short Ratio4.81
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.73%
Min EPS beat(2)8.83%
Max EPS beat(2)14.62%
EPS beat(4)4
Avg EPS beat(4)15.17%
Min EPS beat(4)7.34%
Max EPS beat(4)29.88%
EPS beat(8)4
Avg EPS beat(8)-5.35%
EPS beat(12)6
Avg EPS beat(12)-3.96%
EPS beat(16)10
Avg EPS beat(16)-1.52%
Revenue beat(2)1
Avg Revenue beat(2)2.1%
Min Revenue beat(2)-0.26%
Max Revenue beat(2)4.46%
Revenue beat(4)1
Avg Revenue beat(4)0.78%
Min Revenue beat(4)-0.9%
Max Revenue beat(4)4.46%
Revenue beat(8)1
Avg Revenue beat(8)-1.34%
Revenue beat(12)1
Avg Revenue beat(12)-1.49%
Revenue beat(16)2
Avg Revenue beat(16)-1.88%
PT rev (1m)0%
PT rev (3m)12.06%
EPS NQ rev (1m)0%
EPS NQ rev (3m)9.03%
EPS NY rev (1m)0%
EPS NY rev (3m)10.56%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.45%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3%
Valuation
Industry RankSector Rank
PE 22.62
Fwd PE 15.58
P/S 1.27
P/FCF 12.53
P/OCF 11.07
P/B 1.03
P/tB 31.29
EV/EBITDA 12.03
EPS(TTM)0.86
EY4.42%
EPS(NY)1.25
Fwd EY6.42%
FCF(TTM)1.55
FCFY7.98%
OCF(TTM)1.76
OCFY9.04%
SpS15.36
BVpS18.89
TBVpS0.62
PEG (NY)0.41
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.95%
ROE 1.71%
ROCE 3.73%
ROIC 2.95%
ROICexc 3.82%
ROICexgc 19.84%
OM 7.13%
PM (TTM) 2.11%
GM 54.79%
FCFM 10.1%
ROA(3y)-6.24%
ROA(5y)-2.61%
ROE(3y)-11.58%
ROE(5y)-5.09%
ROIC(3y)4.17%
ROIC(5y)4.15%
ROICexc(3y)4.97%
ROICexc(5y)5.02%
ROICexgc(3y)81.26%
ROICexgc(5y)N/A
ROCE(3y)5.28%
ROCE(5y)5.25%
ROICexcg growth 3Y-55.07%
ROICexcg growth 5Y-3.56%
ROICexc growth 3Y-21.01%
ROICexc growth 5Y-0.5%
OM growth 3Y-26.92%
OM growth 5Y-10.43%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.9%
GM growth 5Y-1.29%
F-Score7
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 5.6
Debt/EBITDA 4.87
Cap/Depr 29.82%
Cap/Sales 1.34%
Interest Coverage 3.77
Cash Conversion 98.48%
Profit Quality 479.37%
Current Ratio 2.44
Quick Ratio 2.08
Altman-Z 1.46
F-Score7
WACC6.92%
ROIC/WACC0.43
Cap/Depr(3y)41.77%
Cap/Depr(5y)41.11%
Cap/Sales(3y)2.19%
Cap/Sales(5y)2.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21.1%
EPS 3Y-28.29%
EPS 5YN/A
EPS Q2Q%136.36%
EPS Next Y55.01%
EPS Next 2Y30.76%
EPS Next 3Y24.3%
EPS Next 5Y33.46%
Revenue 1Y (TTM)0.76%
Revenue growth 3Y0.02%
Revenue growth 5Y1.9%
Sales Q2Q%7.74%
Revenue Next Year4.74%
Revenue Next 2Y4.03%
Revenue Next 3Y3.67%
Revenue Next 5Y7.74%
EBIT growth 1Y-21.02%
EBIT growth 3Y-26.9%
EBIT growth 5Y-8.72%
EBIT Next Year50.22%
EBIT Next 3Y19.79%
EBIT Next 5Y29.05%
FCF growth 1Y61.39%
FCF growth 3Y-0.46%
FCF growth 5Y-1.09%
OCF growth 1Y24.19%
OCF growth 3Y-2.37%
OCF growth 5Y-3.28%